BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28320836)

  • 1. Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence.
    Farnsworth CW; Schott EM; Jensen SE; Zukoski J; Benvie AM; Refaai MA; Kates SL; Schwarz EM; Zuscik MJ; Gill SR; Mooney RA
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28320836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity/type 2 diabetes increases inflammation, periosteal reactive bone formation, and osteolysis during Staphylococcus aureus implant-associated bone infection.
    Farnsworth CW; Schott EM; Benvie AM; Zukoski J; Kates SL; Schwarz EM; Gill SR; Zuscik MJ; Mooney RA
    J Orthop Res; 2018 Jun; 36(6):1614-1623. PubMed ID: 29227579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Gut Microbiota Metabolism in Obesity-Related Type 2 Diabetes Reduces Osteomyelitis Severity.
    Bui TI; Gill AL; Mooney RA; Gill SR
    Microbiol Spectr; 2022 Apr; 10(2):e0017022. PubMed ID: 35315698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A humoral immune defect distinguishes the response to Staphylococcus aureus infections in mice with obesity and type 2 diabetes from that in mice with type 1 diabetes.
    Farnsworth CW; Shehatou CT; Maynard R; Nishitani K; Kates SL; Zuscik MJ; Schwarz EM; Daiss JL; Mooney RA
    Infect Immun; 2015 Jun; 83(6):2264-74. PubMed ID: 25802056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
    Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
    Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbated
    Farnsworth CW; Schott EM; Benvie A; Kates SL; Schwarz EM; Gill SR; Zuscik MJ; Mooney RA
    J Immunol; 2018 Jul; 201(2):560-572. PubMed ID: 29858265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clumping factor A-mediated virulence during Staphylococcus aureus infection is retained despite fibrinogen depletion.
    Palmqvist N; Josefsson E; Tarkowski A
    Microbes Infect; 2004 Feb; 6(2):196-201. PubMed ID: 14998518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus.
    Ní Eidhin D; Perkins S; Francois P; Vaudaux P; Höök M; Foster TJ
    Mol Microbiol; 1998 Oct; 30(2):245-57. PubMed ID: 9791170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
    J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia.
    Flick MJ; Du X; Prasad JM; Raghu H; Palumbo JS; Smeds E; Höök M; Degen JL
    Blood; 2013 Mar; 121(10):1783-94. PubMed ID: 23299312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Staphylococcus aureus Coagulases and Clumping Factor A to Abscess Formation in a Rabbit Model of Skin and Soft Tissue Infection.
    Malachowa N; Kobayashi SD; Porter AR; Braughton KR; Scott DP; Gardner DJ; Missiakas DM; Schneewind O; DeLeo FR
    PLoS One; 2016; 11(6):e0158293. PubMed ID: 27336691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans.
    Elkhatib WF; Hair PS; Nyalwidhe JO; Cunnion KM
    J Med Microbiol; 2015 Apr; 64(Pt 4):335-343. PubMed ID: 25878259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
    Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Herman-Bausier P; Labate C; Towell AM; Derclaye S; Geoghegan JA; Dufrêne YF
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5564-5569. PubMed ID: 29735708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of staphylococcal clumping factor A impedes macrophage phagocytosis.
    Palmqvist N; Patti JM; Tarkowski A; Josefsson E
    Microbes Infect; 2004 Feb; 6(2):188-95. PubMed ID: 14998517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin(ogen) engagement of S. aureus promotes the host antimicrobial response and suppression of microbe dissemination following peritoneal infection.
    Negrón O; Hur WS; Prasad J; Paul DS; Rowe SE; Degen JL; Abrahams SR; Antoniak S; Conlon BP; Bergmeier W; Hӧӧk M; Flick MJ
    PLoS Pathog; 2022 Jan; 18(1):e1010227. PubMed ID: 35041705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
    Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
    Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.